U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07153146) titled 'Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.' on Aug. 22.
Brief Summary: The goal of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PN-881 in healthy adult participants.
Study Start Date: Sept. 08
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: PN-881 Oral Solution
PN-881 Oral Solution
DRUG: PN-881 Oral Tablet
PN-881 oral tablet
DRUG: Placebo
Placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Protagonist Therapeutics, Inc.
Published by HT Digital Content Services with permission from Health Dai...